Implementing pharmacogenomic and genetic testing into prostate cancer clinics

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 45 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 38%
  • Publisher: 51%

Medicine Research News News

Medicine Research,Health Research News,Health Research

Prostate cancer (PC) is a significant health concern, being the second leading cause of death among American men. The standard treatment for advanced PC often involves androgen deprivation therapy (ADT), yet many patients eventually develop resistance, resulting in castration-resistant prostate cancer (CRPC).

Implementing pharmacogenomic and genetic testing into prostate cancer clinics retrieved 31 May 2024 from https://medicalxpress.com/news/2024-05-pharmacogenomic-genetic-prostate-cancer-clinics.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.1 hour ago Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Prostate cancer screening: Longer screening intervals are safe with low baseline prostate-specific antigenRisk-adjusted screening strategies for prostate cancer should help to ensure that fewer men are tested unnecessarily often. According to the experts, this can reduce over-diagnosis and over-treatment, which can cause more harm than good.
Source: medical_xpress - 🏆 101. / 51 Read more »

Research team identifies a new way to treat prostate cancerThe American Cancer Society estimates there are nearly 300,000 new cases of prostate cancer every year in the U.S., and approximately one in eight men will be diagnosed with prostate cancer in their lifetime. Prostate cancer is often treated with androgen deprivation therapy, which lowers testosterone levels to shrink tumors.
Source: medical_xpress - 🏆 101. / 51 Read more »

Author with incurable prostate cancer calls on government to introduce screening programme for menThere is currently no screening programme for prostate cancer despite the fact an estimated 12,000 lives a year are lost to the disease.
Source: SkyNews - 🏆 35. / 67 Read more »

Plant-based diet may aid prostate cancer outcomesConsuming a primarily plant-based diet may be associated with better cancer-specific health outcomes among men with prostate cancer, according to a study published online May 1 in JAMA Network Open.
Source: medical_xpress - 🏆 101. / 51 Read more »

What is the association between post-diagnostic plant-based dietary patterns and the risk of prostate cancer progression?The relationship between the risk of progression of prostate cancer and plant-based diet adherence.
Source: NewsMedical - 🏆 19. / 71 Read more »